Search: MRK - Buzzberg

Date	Ticker	Price	Dir	Speaker	Thesis	Source
Feb 18	MRK	$121.66 $121.66 +0.0%	N/A	Finnhub News	—	Finnhub - MRK Merck (MRK) Valuation Check As Keytruda SC Ap...
Feb 18	MRK	$121.66 $121.66 +0.0%	N/A	Finnhub News	—	Finnhub - MRK Moderna stock surges as FDA reverses course, ...
Feb 18	MRK	$121.66 $121.66 +0.0%	N/A	Finnhub News	—	Finnhub - MRK Cancer Vaccines Competitive Landscape Report ...
Feb 18	MRK	$121.66 $121.66 +0.0%	N/A	Finnhub News	—	Finnhub - MRK Merck & Co. (MRK) Advances on Robust Keytruda...
Feb 18	MRK	$121.66 $121.66 +0.0%	N/A	Finnhub News	—	Finnhub - MRK Merck and Mayo Clinic Announce New Research a...
Feb 18	MRK	$121.66 $121.66 +0.0%	N/A	Finnhub News	—	Finnhub - MRK $198.39 Bn Active Pharmaceutical Ingredients ...
Feb 18	MRK	$121.66 $121.66 +0.0%	N/A	Finnhub News	—	Finnhub - MRK The Patent Cliff Is a Hill: Why Merck's Diver...
Feb 18	MRK	$121.66 $121.66 +0.0%	N/A	Finnhub News	—	Finnhub - MRK Merck And Mayo Clinic Announce R&D Agreement ...
Feb 17	MRK	$121.57 $121.66 +0.1%	N/A	Finnhub News	—	Finnhub - MRK HALOZYME REPORTS FULL YEAR 2025 RECORD REVENU...
Feb 17	MRK	$121.57 $121.66 +0.1%	N/A	Finnhub News	—	Finnhub - MRK Did New KEYTRUDA Approvals Just Shift Merck’s...
Feb 17	MRK	$121.57 $121.66 +0.1%	N/A	Finnhub News	—	Finnhub - MRK Health Canada Approves KEYTRUDA SC™, a subcut...
Feb 17	MRK	$121.57 $121.66 +0.1%	N/A	Finnhub News	—	Finnhub - MRK Can BMY's Growth Portfolio Counter Legacy Dru...
Feb 17	MRK	$121.57 $121.66 +0.1%	N/A	Finnhub News	—	Finnhub - MRK Recursion Pharmaceuticals to Report Q4 Earnin...
Feb 17	MRK	$121.57 $121.66 +0.1%	N/A	Finnhub News	—	Finnhub - MRK Merck's KEYTRUDA SC Receives Health Canada Ap...
Feb 16	MRK	$121.41 $121.66 +0.2%	N/A	Finnhub News	—	Finnhub - MRK Merck Indicates Better Growth Visibility in P...
Feb 14	MRK	$121.41 $121.66 +0.2%	LONG	Finnhub News	Merck's Keytruda has expanded its approved uses, which is a positive development for the company, despite ongoing valuation concerns.	Finnhub - MRK Merck’s KEYTRUDA Wins New Ovarian Cancer Use ...
Feb 13	MRK	$121.41 $121.66 +0.2%	N/A	Finnhub News	—	Finnhub - MRK Moderna Q4 Loss Narrower-Than-Expected, Sales...
Feb 13	MRK	$121.41 $121.66 +0.2%	N/A	Finnhub News	—	Finnhub - MRK MRK Up More Than 7% on Improved Long-Term Pro...
Feb 13	MRK	$121.41 $121.66 +0.2%	N/A	Finnhub News	—	Finnhub - MRK Merck & Co. (MRK) Announces FDA Approval of K...
Feb 13	MRK	$121.41 $121.66 +0.2%	N/A	Finnhub News	—	Finnhub - MRK Can Gilead's HIV Portfolio Sustain Its Growth...
Feb 13	MRK	$121.41 $121.66 +0.2%	N/A	Finnhub News	—	Finnhub - MRK Is Merck (MRK) a Buy as Wall Street Analysts ...
Feb 13	MRK	$121.41 $121.66 +0.2%	N/A	Finnhub News	—	Finnhub - MRK Merck & Co., Inc. (MRK) is Attracting Investo...
Feb 13	MRK	$121.41 $121.66 +0.2%	N/A	Finnhub News	—	Finnhub - MRK Analysis-China biotech licensing boom to hit ...
Feb 13	MRK	$121.41 $121.66 +0.2%	N/A	Finnhub News	—	Finnhub - MRK 3 Mega-Cap Stocks for Long-Term Investors
Feb 12	MRK	$119.24 $121.66 +2.0%	N/A	Finnhub News	—	Finnhub - MRK Sanofi ousts CEO Hudson after stalled turnaro...
Feb 12	MRK	$119.24 $121.66 +2.0%	N/A	Finnhub News	—	Finnhub - MRK Merck Advances Treatment of Bladder and Kidne...
Feb 12	MRK	$119.24 $121.66 +2.0%	N/A	Finnhub News	—	Finnhub - MRK Sanofi replaces chief Paul Hudson with Merck ...
Feb 12	MRK	$119.24 $121.66 +2.0%	N/A	Finnhub News	—	Finnhub - MRK Merck’s Ovarian Cancer Wins Tested Against Va...
Feb 12	MRK	$119.24 $121.66 +2.0%	N/A	Finnhub News	—	Finnhub - MRK Merck: Keytruda Remains Resilient Despite LOE...
Feb 12	MRK	$119.24 $121.66 +2.0%	N/A	Finnhub News	—	Finnhub - MRK Merck To Present Data Across Multiple Genitou...
Feb 11	MRK	$119.31 $121.66 +2.0%	N/A	Finnhub News	—	Finnhub - MRK Sector Update: Health Care Stocks Rise Late A...
Feb 11	MRK	$119.31 $121.66 +2.0%	N/A	Finnhub News	—	Finnhub - MRK Merck & Co. Inc. stock outperforms competitor...
Feb 11	MRK	$119.31 $121.66 +2.0%	N/A	Finnhub News	—	Finnhub - MRK EXEL Q4 Earnings and Revenues Beat, Colorecta...
Feb 11	MRK	$119.31 $121.66 +2.0%	N/A	Finnhub News	—	Finnhub - MRK Moderna: FDA RTF Derails mRNA-1010 And Reigni...
Feb 11	MRK	$119.31 $121.66 +2.0%	N/A	Finnhub News	—	Finnhub - MRK KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ ...
Feb 11	MRK	$119.31 $121.66 +2.0%	N/A	Finnhub News	—	Finnhub - MRK Agilent Receives FDA Approval for PD-L1 IHC 2...
Feb 11	MRK	$119.31 $121.66 +2.0%	N/A	Finnhub News	—	Finnhub - MRK Merck's Keytruda Gets New FDA Approval For Ex...
Feb 11	MRK	$119.31 $121.66 +2.0%	N/A	Finnhub News	—	Finnhub - MRK The FDA Approves Merck's Keytruda And Keytrud...

Search

Trade Ideas (38)